SEPN - Company ID 0001984086
Septerna, Inc. trades as SEPN and has a market capitalization of $1.71 B, making it the #2272 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $45.95M, up 4174.5% from the prior year and net income of -$48.88M. This page tracks Septerna, Inc. through 129 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-10
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Net profit margin compressed from 2768.2% to -106.4% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-26 |
| Quarterly report | 10-Q | 2026-05-11 |
| Major company event | 8-K | 2026-05-11 |
| Annual report to shareholders | ARS | 2026-04-30 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
| Insider trade | 4 | 2026-04-17 |
| Major company event | 8-K | 2026-04-13 |
Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer
The largest companies sharing Septerna, Inc.'s SEC industry classification (pharmaceutical preparations).
Septerna, Inc. (SEPN) has a market capitalization of $1.71 B as of 2026-07-10, ranking #2272 among US-listed companies.
Septerna, Inc. reported revenue of $45.95M for fiscal year 2025, an increase of 4174.5% year over year.
In its latest fiscal year Septerna, Inc. reported a net loss of $48.88M.